Shots: Boston Scientific to acquire Preventice for ~$1.2B including $925M as up front, up to an additional $300M as commercial milestones. However, Boston Scientific has built up a 22% stake in Preventice, which is expected to lower up front to $720M upfront & $230 million in milestone respectively The acquisition is expected to be close […]Read More
Shots: Qiagen’s QIAstat-Dx and NeuMoDx tests remain accurate & effective in detecting SARS-CoV-2 infections The company started cross-checking variants in May’2020 & assessed the tests against genetic mutations of the virus uploaded to the GISAID and GenBank public databases. Qiagen will continue to conduct assessments on a biweekly basis Variants with potentially increased transmissibility include […]Read More
Shots: Cardiva to receive $475M up front and up to an additional ~$35M in contingent consideration based on sales growth. The transaction is expected to be completed in Q1’21 The acquisition expands Haemonetics’ blood transfusion and loss management offerings and enhance its penetration into the large and growing interventional cardiology and electrophysiology markets Cardiva’s portfolio […]Read More
Shots: Thermo Fisher acquires Mesa Biotech for $450M in cash. Mesa Biotech will receive an additional ~$100M in cash on the completion of milestones while the transaction is expected to be completed in Q1’21 Mesa has developed & commercialized a PCR-based rapid POC testing platform for detecting infectious diseases. Messa’s technology inflates the availability of […]Read More
Shots: Hologic acquires Biotheranostics to speed up its entry in the oncology market. The transaction is expected to be completed in Feb’2021 The acquisition will provide Hologic access to Biotheranostics’ CLIA lab and will aid in accelerating market development for novel tests The acquisition allows Hologic to leverage commercial capabilities and expertise in molecular diagnostics […]Read More
Shots: The US FDA has granted EUA to Nirmidas’ COVID-19 rapid antibody IgG/IgM test for use in POC settings, delivering results in 15-20min Using a fingerstick serology test, the MidaSpot COVID-19 Ab combo detection kit checks for Ab against the RBD antigen and showed 100% sensitivity for IgG after 14 days post symptom onset and […]Read More
Shots: Stryker acquires OrthoSensor and its Verasense intraoperative sensor tech, enhancing the ortho giant’s Mako robots The acquisition allows Stryker to empower surgeons with comprehensive data-driven solutions. The sensor tech will boost Mako surgical robotics systems, enhancing workflow through one complete data-driven feedback mechanism Moreover, OrthoSensor’s MotionSense remote patient monitoring wearables and mobile application combined […]Read More
Shots: Early results from TemPredict study conducted at the University of California unveils that the Oura Ring’s continuous temperature monitoring could detect fevers before patients began to experience symptoms, suggesting that the technology could function as an early warning system for COVID-19 The ring measures health parameters, including heart rate, activity levels, temperature, and respiratory […]Read More
Shots. The company has submitted MAA to COFEPRIS (the health regulatory authority for Mexico) for its COVI-STIX rapid diagnostic test to detect SARS-CoV-2 virus nucleocapsid antigen in nasal samples of patients The test provides results in 15min. with positive detection as quickly as 2min for patient samples with high viral load. Additionally, Sorrento is also […]Read More
Shots: The FDA has issued a EUA for Simoa Semi-Quantitative SARS-CoV-2 IgG Ab test and can be operated on Simoa HD-X Analyzer The test checks for Abs that are directed against the spike protein. The test delivers a numerical result demonstrating Ab concentration ranging from 0.21-250mg/mL. The clinical studies demonstrated that the test had a […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
